Loading company…
San Francisco-based biopharmaceutical company developing drug therapies for cancer.
Founded in San Francisco, US, Novacea, Inc. develops cancer drug candidates through research and clinical trials. The company went public in May 2006, raising USD 40.63 mn by selling 6.25 million shares at USD 6.5 each. Transcept Pharmaceuticals, Inc. acquired the company in January 2009, and it reported revenue of USD 160.27 mn and EBITDA of USD -45.72 mn for fiscal 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in